Corporate News 08-Mar-22
Aleor Dermaceuticals receives USFDA approval for Nystatin and Triamcinolone Acetonide Ointment
Alembic Pharmaceuticals (Alembic) today announced that its joint venture Aleor Dermaceuticals (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 U/g/0.1 %, of Taro Pharmaceuticals U.S.A. Inc. Nystatin and Triamcinolone Acetonide Ointment is indicated for the treatment of cutaneous candidiasis; it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment.
Previous News
Alembic Pharmaceuticals consolidated net profit rises 2.41% in the September 2023 quarter
( Results - Announcements 07-Nov-23 15:08 )
Alembic Pharma gets USFDA nod for Paliperidone extended-release Tablets
( Hot Pursuit - 27-Sep-24 13:40 )
Alembic Pharmaceuticals reports consolidated net profit of Rs 120.60 crore in the June 2023 quarter
( Results - Announcements 04-Aug-23 14:15 )
Alembic Pharma gets USFDA nod for Doxycycline Capsules
( Hot Pursuit - 28-Jun-24 12:20 )
Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules
( Corporate News - 13-Aug-24 12:15 )
Alembic Pharmaceuticals receives USFDA approval for Betamethasone Valerate Foam
( Corporate News - 24-Aug-24 14:03 )
Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr
( Hot Pursuit - 08-Aug-24 15:48 )
Alembic Pharmaceuticals consolidated net profit rises 596.17% in the March 2023 quarter
( Results - Announcements 05-May-23 17:32 )
Alembic Pharmaceuticals receives USFDA's tentative approval for Acalabrutinib Capsules
( Corporate News - 19-Jan-23 14:19 )
Board of Alembic Pharmaceuticals recommends Final Dividend
( Corporate News - 05-May-23 17:26 )
Alembic Pharma gains after USFDA tentative nod for Acalabrutinib capsules
( Hot Pursuit - 19-Jan-23 14:12 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
